The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver DiseaseDirk P. van Asseldonk, Ad A. van Bodegraven, Dik B. Westerveld et al.|Inflammatory Bowel Diseases|2016Cited by 45
Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patientsDirk P. van Asseldonk, Adriaan A. van Bodegraven, Melek Simsek et al.|Scandinavian Journal of Gastroenterology|2019Cited by 11